Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1217949 | 1.00 | LMNA (0.32) | LMNA | |
| SCHEMBL1694398 | 0.97 | — | — | |
| SCHEMBL27429949 | 0.93 | LMNA (0.31) | LMNA | |
| SCHEMBL1681713 | 0.93 | LMNA (0.31) | LMNA | |
| SCHEMBL9745888 | 0.92 | — | — | |
| SCHEMBL27804547 | 0.91 | — | — | |
| SCHEMBL14214378 | 0.91 | — | — | |
| SCHEMBL1471679 | 0.90 | — | — | |
| SCHEMBL14603605 | 0.90 | — | — | |
| SCHEMBL10423230 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3645634-B1 | FLUORINATED ESTER COMPOUND ADDITIVES FOR ARCHITECTURAL COATINGS | CHEMOURS CO FC LLC (US) | 2022-12-28 | — | — | EP | disclosed |
| US-11518894-B2 | Fluorinated ester compound additives for architectural coatings | THE CHEMOURS COMPANY FC, LLC (US) | 2022-12-06 | — | — | US | disclosed |
| WO-2022097043-A1 | SILICON-CONTAINING COMPOUNDS FOR FORMING A PATTERNING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2022-05-12 | — | — | WO | disclosed |
| US-10466591-B2 | Fluorine-containing composition, substrate for pattern formation, photodegradable coupling agent, pattern formation method and transistor production method | NIKON CORPORATION (JP) | 2019-11-05 | — | — | US | disclosed |
| US-9932316-B2 | Imidazolium salts having liquid crystal characteristics, useful as electrolytes | DAUNIA SOLAR CELL S.R.L. (IT) | 2018-04-03 | — | — | US | disclosed |
| US-20170285471-A1 | FLUORINE-CONTAINING COMPOSITION, SUBSTRATE FOR PATTERN FORMATION, PHOTODEGRADABLE COUPLING AGENT, PATTERN FORMATION METHOD AND TRANSISTOR PRODUCTION METHOD | NIKON CORPORATION (JP) | 2017-10-05 | — | — | US | disclosed |
| US-20170285471-A1 | FLUORINE-CONTAINING COMPOSITION, SUBSTRATE FOR PATTERN FORMATION, PHOTODEGRADABLE COUPLING AGENT, PATTERN FORMATION METHOD AND TRANSISTOR PRODUCTION METHOD | NIKON CORPORATION (JP) | 2017-10-05 | — | — | US | disclosed |
| US-20160152642-A1 | FLOURINE-CONTAINING COMPOUND, SUBSTRATE FOR PATTERNING, PHOTODEGRADABLE COUPLING AGENT, PATTERNING METHOD, AND COMPOUND | KANAGAWA UNIVERSITY (JP) | 2016-06-02 | — | — | US | disclosed |
| EP-2440532-B1 | Imidazolium salts having liquid crystal characteristics, useful as electrolytes | DAUNIA SOLAR CELL S R L (IT) | 2015-08-05 | — | — | EP | disclosed |
| US-20120135316-A1 | NEW IMIDAZOLIUM SALTS HAVING LIQUID CRYSTAL CHARACTERISTICS, USEFUL AS ELECTROLYTES | DAUNIA SOLAR CELL S.R.L. (IT) | 2012-05-31 | — | — | US | disclosed |
| EP-2440532-A2 | NEW IMIDAZOLIUM SALTS HAVING LIQUID CRYSTAL CHARACTERISTICS, USEFUL AS ELECTROLYTES | Daunia Solar Cell S.r.l. (IT) | 2012-04-18 | — | — | EP | disclosed |
| WO-2010142445-A2 | NEW IMIDAZOLIUM SALTS HAVING LIQUID CRYSTAL CHARACTERISTICS, USEFUL AS ELECTROLYTES | DAUNIA SOLAR CELL S.R.L. (IT) | 2010-12-16 | — | — | WO | disclosed |
| EP-2261217-A1 | Imidazolium salts having liquid crystal characteristics, useful as electrolytes | Politecnico di Milano (IT) | 2010-12-15 | — | — | EP | disclosed |
| EP-1610176-A2 | UV decomposable molecules and a photopatternable monomolecular film formed therefrom | SEIKO EPSON CORPORATION (JP) | 2005-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135316-A1 | NEW IMIDAZOLIUM SALTS HAVING LIQUID CRYSTAL CHARACTERISTICS, USEFUL AS ELECTROLYTES | KCNH2, KCNH3, HCN2 | LMNA 1027/4885 |
| US-20160152642-A1 | FLOURINE-CONTAINING COMPOUND, SUBSTRATE FOR PATTERNING, PHOTODEGRADABLE COUPLING AGENT, PATTERNING METHOD, AND COMPOUND | AFF1, AFF2, AFF4 | LMNA 2813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.